Repligen Overview
Repligen Target Price
Analysts' 12-month price predictions for RGEN.
Get informed when a big investor buys or sells
+ FollowShare Price
$130.59
Average Target Price
$150.40
15.2% upside
15.2% upside5 analysts in the last 4 months
High: $160 | Low: $142
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-14 | RBC CapitalDan Leonard | $160 | 22.5% upside |  |
| 2026-05-05 | JefferiesMatthew Stanton | $142 | 8.7% upside | |
| 2026-04-20 | Canaccord Genuity | $145 | 11% upside | |
| 2026-04-17 | Redburn Partners | $160 | 22.5% upside | |
| 2026-04-14 | BarclaysLuke Sergott | $145 | 11% upside | |
| 2026-01-16 | UBSDan Leonard | $200 | 53.2% upside | |
| 2025-12-15 | Barclays | $200 | 53.2% upside | |
| 2025-12-15 | Wells Fargo | $190 | 45.5% upside | |
| 2025-10-29 | Canaccord Genuity | $165 | 26.3% upside | |
| 2025-10-29 | Barclays | $175 | 34% upside | |
| 2025-10-28 | JefferiesMatthew Stanton | $160 | 22.5% upside | |
| 2025-10-02 | BarclaysLuke Sergott | $160 | 22.5% upside | |
| 2025-10-01 | HSBC | $150 | 14.9% upside | |
| 2025-09-02 | RBC Capital | $205 | 57% upside | |
| 2024-11-12 | KeyBancPaul Knight | $220 | 68.5% upside | |
| 2024-07-31 | J.P. MorganRachel Vatnsdal | $200 | 53.2% upside | |
| 2024-07-31 | UBSElizabeth Garcia | $185 | 41.7% upside | |
| 2024-06-26 | Deutsche BankJustin Bowers | $155 | 18.7% upside | |
| 2024-06-21 | Stifel NicolausDaniel Arias | $207 | 58.5% upside | |
| 2023-01-06 | Leerink Partners | $200 | 53.2% upside | |
| 2022-12-14 | Deutsche Bank | $180 | 37.8% upside | |
| 2022-12-07 | RBC Capital | $190 | 45.5% upside | |
| 2022-04-28 | Leerink Partners | $220 | 68.5% upside | |